Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism

References

1. 1.↵
   2. van der Holst HM,
   3. van Uden IW,
   4. Tuladhar AM, et al

   . Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology 2015;85:1569–77 doi:10.1212/WNL.0000000000002082 pmid:26446068

   CrossRefPubMed
2. 2.↵
   2. Caslake R,
   3. Taylor K,
   4. Scott N, et al

   . Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study. Parkinsonism Relat Disord 2014;20:834–39 doi:10.1016/j.parkreldis.2014.04.013 pmid:24814713

   CrossRefPubMed
3. 3.↵
   2. Vale TC,
   3. Caramelli P,
   4. Cardoso F

   . Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease. J Neurol Neurosurg Psychiatry 2015;86:547–53 doi:10.1136/jnnp-2014-307867 pmid:25006209

   Abstract/FREE Full Text
4. 4.↵
   2. Benitez-Rivero S,
   3. Lama MJ,
   4. Huertas-Fernandez I, et al

   . Clinical features and neuropsychological profile in vascular parkinsonism. J Neurol Sci 2014;345:193–97 doi:10.1016/j.jns.2014.07.046 pmid:25108818

   CrossRefPubMed
5. 5.↵
   2. Demirkiran M,
   3. Bozdemir H,
   4. Sarica Y

   . Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001;104:63–67 doi:10.1034/j.1600-0404.2001.104002063.x pmid:11493219

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Rampello L,
   3. Alvano A,
   4. Battaglia G, et al

   . Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol 2005;252:1045–49 doi:10.1007/s00415-005-0811-2 pmid:15940389

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Zijlmans JC,
   3. Thijssen HO,
   4. Vogels OJ, et al

   . MRI in patients with suspected vascular parkinsonism. Neurology 1995;45:2183–88 doi:10.1212/WNL.45.12.2183 pmid:8848190

   Abstract/FREE Full Text
8. 8.↵
   2. Gibb WR,
   3. Lees AJ

   . The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989;15:27–44 doi:10.1111/j.1365-2990.1989.tb01147.x pmid:2542825

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Zijlmans JC,
   3. Daniel SE,
   4. Hughes AJ, et al

   . Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19:630–40 doi:10.1002/mds.20083 pmid:15197700

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Goetz CG,
    3. Tilley BC,
    4. Shaftman SR, et al

    ; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129–70 doi:10.1002/mds.22340 pmid:19025984

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Bensimon G,
    3. Ludolph A,
    4. Agid Y, et al

    . Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009;132:156–71 doi:10.1093/brain/awn291 pmid:19029129

    Abstract/FREE Full Text
12. 12.↵
    1. Spreen O,
    2. Strauss E

    , eds. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press; 1991
13. 13.↵
    2. Schmitter D,
    3. Roche A,
    4. Maréchal B, et al

    ; Alzheimer's Disease Neuroimaging Initiative. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease. Neuroimage Clin 2015;7:7–17 doi:10.1016/j.nicl.2014.11.001 pmid:25429357

    CrossRefPubMed
14. 14.↵
    2. Wang L,
    3. Zang Y,
    4. He Y, et al

    . Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 2006;31:496–504 doi:10.1016/j.neuroimage.2005.12.033 pmid:16473024

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Behzadi Y,
    3. Restom K,
    4. Liau J, et al

    . A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007;37:90–101 doi:10.1016/j.neuroimage.2007.04.042 pmid:17560126

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Manza P,
    3. Zhang S,
    4. Hu S, et al

    . The effects of age on resting state functional connectivity of the basal ganglia from young to middle adulthood. Neuroimage 2015;107:311–22 doi:10.1016/j.neuroimage.2014.12.016 pmid:25514518

    CrossRefPubMed
17. 17.↵
    2. Gruber SA,
    3. Rogowska J,
    4. Holcomb P, et al

    . Stroop performance in normal control subjects: an fMRI study. Neuroimage 2002;16:349–60 doi:10.1006/nimg.2002.1089 pmid:12030821

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Vogt BA

    . Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 2005;6:533–44 doi:10.1038/nrn1704 pmid:15995724

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Vizcarra JA,
    3. Lang AE,
    4. Sethi KD, et al

    . Vascular Parkinsonism: deconstructing a syndrome. Mov Disord 2015;30:886–94 doi:10.1002/mds.26263 pmid:25997420

    CrossRefPubMed
20. 20.↵
    2. Korczyn AD

    . Vascular contribution to dementia in Parkinson's disease. Neurodegener Dis 2010;7:127–30 doi:10.1159/000285522 pmid:20173342

    CrossRefPubMed
21. 21.↵
    2. Chen YF,
    3. Tseng YL,
    4. Lan MY, et al

    . The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism. J Neurol Sci 2014;346:255–59 doi:10.1016/j.jns.2014.09.002 pmid:25240444

    CrossRefPubMed
22. 22.↵
    2. Santangelo G,
    3. Vitale C,
    4. Trojano L, et al

    . Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord 2010;25:50–56 doi:10.1002/mds.22893 pmid:20014112

    CrossRefPubMed
23. 23.↵
    2. Poletti M,
    3. Bonuccelli U

    . Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review. Ther Adv Psychopharmacol 2013;3:101–13 doi:10.1177/2045125312470130 pmid:24167681

    Abstract/FREE Full Text
24. 24.↵
    2. Molloy SA,
    3. Rowan EN,
    4. O'Brien JT, et al

    . Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:1323–28 doi:10.1136/jnnp.2006.098079 pmid:16952917

    Abstract/FREE Full Text
25. 25.↵
    2. Kulisevsky J,
    3. García-Sánchez C,
    4. Berthier ML, et al

    . Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord 2000;15:613–26 pmid:10928571

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Torta DM,
    3. Cauda F

    . Different functions in the cingulate cortex, a meta-analytic connectivity modeling study. Neuroimage 2011;56:2157–72 doi:10.1016/j.neuroimage.2011.03.066 pmid:21459151

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Beckmann M,
    3. Johansen-Berg H,
    4. Rushworth MF

    . Connectivity-based parcellation of human cingulate cortex and its relation to functional specialization. J Neurosci 2009;29:1175–90 doi:10.1523/JNEUROSCI.3328-08.2009 pmid:19176826

    Abstract/FREE Full Text
28. 28.↵
    2. Hacker CD,
    3. Perlmutter JS,
    4. Criswell SR, et al

    . Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012;135:3699–711 doi:10.1093/brain/aws281 pmid:23195207

    Abstract/FREE Full Text
29. 29.↵
    2. Margulies DS,
    3. Kelly AM,
    4. Uddin LQ, et al

    . Mapping the functional connectivity of anterior cingulate cortex. Neuroimage 2007;37:579–88 doi:10.1016/j.neuroimage.2007.05.019 pmid:17604651

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Rauch SL,
    3. Kim H,
    4. Makris N, et al

    . Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg 2000;93:1019–25 doi:10.3171/jns.2000.93.6.1019 pmid:11117844

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Abela E,
    3. Seiler A,
    4. Missimer JH, et al

    . Grey matter volumetric changes related to recovery from hand paresis after cortical sensorimotor stroke. Brain Struct Funct 2015;220:2533–50 doi:10.1007/s00429-014-0804-y pmid:24906703

    CrossRefPubMed
32. 32.↵
    2. Weissman DH,
    3. Roberts KC,
    4. Visscher KM, et al

    . The neural bases of momentary lapses in attention. Nat Neurosci 2006;9:971–78 doi:10.1038/nn1727 pmid:16767087

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Damoiseaux JS,
    3. Beckmann CF,
    4. Arigita EJ, et al

    . Reduced resting-state brain activity in the “default network” in normal aging. Cereb Cortex 2008;18:1856–64 doi:10.1093/cercor/bhm207 pmid:18063564

    Abstract/FREE Full Text
34. 34.↵
    2. Lin P,
    3. Yang Y,
    4. Jovicich J, et al

    . Static and dynamic posterior cingulate cortex nodal topology of default mode network predicts attention task performance. Brain Imaging Behav 2016;10:212–25 doi:10.1007/s11682-015-9384-6 pmid:25904156

    CrossRefPubMed
35. 35.↵
    2. Leung HC,
    3. Skudlarski P,
    4. Gatenby JC, et al

    . An event-related functional MRI study of the Stroop color word interference task. Cereb Cortex 2000;10:552–60 doi:10.1093/cercor/10.6.552 pmid:10859133

    Abstract/FREE Full Text
36. 36.↵
    2. Eichele T,
    3. Debener S,
    4. Calhoun VD, et al

    . Prediction of human errors by maladaptive changes in event-related brain networks. Proc Natl Acad Sci U S A 2008;105:6173–78 doi:10.1073/pnas.0708965105 pmid:18427123

    Abstract/FREE Full Text
37. 37.↵
    2. Li CS,
    3. Yan P,
    4. Bergquist KL, et al

    . Greater activation of the “default” brain regions predicts stop signal errors. Neuroimage 2007;38:640–48 doi:10.1016/j.neuroimage.2007.07.021 pmid:17884586

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Leech R,
    3. Sharp DJ

    . The role of the posterior cingulate cortex in cognition and disease. Brain 2014;137:12–32 doi:10.1093/brain/awt162 pmid:23869106

    Abstract/FREE Full Text